The following fields were updated due to additional information: d10: device available for eval yes.D10: returned to manufacturer on: 01-dec-2022.H6: investigation summary: to aid in the investigation of this issue, six (6) 10ml syringes and six (6) 5ml syringes were returned for evaluation by our quality engineer team.All of the twelve (12) syringes were received in their original, unopened blister packaging.However, only four (4) of the syringes belonged to the lot numbers reported in this event.Unfortunately, testing was not conducted on the returned samples, as they were not controlled/handled appropriately during the shipment return process.The returned samples were loose within a courier bag outside of their original secondary packaging (shelf carton), so it could not be determined if the sterility barrier of the package had been breached or damaged in transit.A device history record review was completed for provided material number 306582 and batch numbers 1196818 and 1251978.The review did not reveal any non-conformances during the production process that could have contributed to the reported incident.
|